Hussman Strategic Advisors’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,200
Closed -$658K 290
2024
Q4
$658K Buy
+4,200
New +$658K 0.19% 172